Answers are grounded in this paper and cite their sources.
To characterize largazole's structural requirements for histone deacetylase (HDAC) inhibitory and antiproliferative activities, a series of analogues with modifications to the side chain or 16-membered macrocycle were prepared and biologically evaluated. Structure-activity relationships suggested that the four-atom linker between the macrocycle and octanoyl group in the side chain and the (S)-configuration at the C17 position are critical to repression of HDAC activity. However, the valine residue in the macrocycle can be replaced with alanine without significant loss of activity.
No takes yet. Share an insight, caveat, or question.
Ying et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: